Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhenwen Zhou has a total of 143 co-authors. Here are the top co-authors by number of shared publications:

  • Bingshao Liang

    Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510095, Guangdong, China

    18 shared publications
  • Chao Zhang

    Clinical Laboratory, Key Laboratory of Bacterial Resistance and Prevention, Medical Research Institute of Maternal and Child, Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College (Longgang District Maternity & Child Healthcare Hospital of Shenzhen City)

    14 shared publications
  • Jialiang Mai

    Longgang Maternity and Child Institute of Shantou University Medical College (Longgang District Maternity & Child Healthcare Hospital of Shenzhen City), Clinical Laboratory, Shenzhen, 518172, Guangdong, China; Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510095, Guangdong, China

    14 shared publications
  • Zhile Xiong

    Clinical Laboratory, Key Laboratory of Bacterial Resistance and Prevention, Medical Research Institute of Maternal and Child, Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College (Longgang District Maternity & Child Healthcare Hospital of Shenzhen City)

    14 shared publications
  • Sitang Gong

    Department of Gastroenterology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of China

    13 shared publications
  • Zhuwei Liang

    Clinical Laboratory, Longgang Maternity and Child Institute of Shantou University Medical College (Longgang District Maternity & Child Healthcare Hospital of Shenzhen City), Shenzhen, Guangdong, China

    13 shared publications

Latest Publications

  • Open Access

    Detection characteristics and antimicrobial resistance profiles of Salmonella spp. isolated from fecal cultures of inpatients at a maternal and child healthcare hospital in Shenzhen: a 5-year retrospective study

    by Tongyan Ding, Shaoxiang Lin, Xiaochun Liu, Shujuan Yang, Futing Liao, Qiaoxin Zhang, Zhenwen Zhou

    Salmonella spp. remain an important cause of bacterial gastrointestinal infection, but local data from maternal and child healthcare hospitals remain limited. This retrospective study analyzed Salmonella spp. isolated from fecal cultures of inpatients at Longgang District Maternity and Child Healthcare Hospital of Shenzhen City from 2021 to 2025. Fecal specimens were processed using routine selective culture procedures; isolates were identified with the VITEK 2 Compact system, with VITEK MS confirmation when required, and antimicrobial susceptibility was interpreted according to Clinical and Laboratory Standards Institute (CLSI) M100, 35th edition. Annual positivity and non-duplicate isolation rates were compared using Pearson χ 2 tests. A total of 106 non-duplicate isolates were recovered, including 98 from pediatric inpatients. Annual positivity and non-duplicate isolation rates differed significantly across the 5-year study period (both P < 0.001) and were highest in 2025. Among pediatric cases, children aged 1–3 years accounted for 79.6%, with the 12 to Salmonella among children aged 1–3 years, particularly those aged 12 to Salmonella spp. remain an important bacterial cause of gastrointestinal infection in children, but local data from maternal and child healthcare hospitals are limited. This 5-year retrospective study describes the detection characteristics and antimicrobial resistance profiles of Salmonella spp. isolated from fecal cultures of inpatients in a maternal and child healthcare hospital in Shenzhen, China. The findings show that Salmonella isolates were mainly recovered from young pediatric patients and exhibited high resistance to several commonly used antimicrobial agents, including ampicillin, ampicillin/sulbactam, trimethoprim-sulfamethoxazole, and ceftriaxone, while reduced susceptibility to fluoroquinolones was also observed. These results provide institution-specific evidence for empirical treatment decisions, antimicrobial stewardship, and continued surveillance of enteric bacterial pathogens in pediatric and maternal-child healthcare settings.

  • Expression and Purification of Staphylococcal Enterotoxin B and Detection of SEB-Specific IgG Antibodies in Allergic Children

    by Huixin Gao, Yuqian Yan, Qingling Ma, Xiaolan Ai, Hao Zheng, Zhenwen Zhou, Yunfeng Liu

    Objective: This study aims to express and purify staphylococcal enterotoxin B (SEB) and to detect and analyze the levels of SEB-specific IgG antibodies in the serum of children with food or aeroallergen allergies using an enzyme-linked immunosorbent assay (ELISA). Methods: SEB protein was expressed and purified in a recombinant pET-28 α (+)-SEB E. coli system. The purified SEB protein was used as an antigen to detect SEB-IgG antibody levels in the serum of 100 clinically confirmed cases of food-allergic and aeroallergen-allergic children, and the results were compared with those of 50 healthy children using ELISA. Results: The recombinant SEB protein, with a molecular weight of approximately 35 kDa, was successfully expressed and purified. ELISA results showed that the SEB-IgG antibody levels in the serum of food-allergic and aeroallergen-allergic children (OD450 values of 0.30 ± 0.03 and 0.31 ± 0.04, respectively) were significantly higher than those in the normal control group (0.24 ± 0.05, P < .05). However, there was no significant difference in SEB-IgG antibody levels between food-allergic children and aeroallergen-allergic children ( P > .05). The positive rate of SEB-IgG antibodies was 68% in aeroallergen-allergic children and 56% in food-allergic children. SEB-IgG positivity increased with the number of allergens but was not correlated with the severity of the allergy. Conclusion: This study successfully expressed and purified SEB protein in a prokaryotic system. We found that SEB-IgG antibody levels were significantly higher in allergic children compared to healthy controls and were related to the number of allergens. These results suggest an association between SEB exposure and allergic diseases in the pediatric population, highlighting its potential role as an immunomodulator and laying a foundation for further mechanistic and clinical investigations.

  • Open Access

    Recombinant Bacillus subtilis spores expressing cholera toxin B and ovalbumin prevent ovalbumin-specific food allergy in mice by upregulating regulatory T cells and modulating gut microbiome flora

    by Zhile Xiong, Xiuju Liu, Xiaoying Deng, Chao Zhang, Kaiyue Yang, Zhimin Zhao, Tongyan Ding, Shuyan Liu, Zhenwen Zhou

    Background: Although oral immunotherapy has shown clinical efficacy in treating food allergies, its broader implementation is constrained by the occurrence of adverse effects. Consequently, inducing allergen-specific immune tolerance during early life can be a preventive strategy to reduce the development of food allergy. Objective: Here, we developed a novel fusion protein cholera toxin B (CTB)-ovalbumin (OVA) expressed on Bacillus subtilis ( B.s -CotC-CTB-OVA) spore surface and investigated whether B.s -CotC-CTB-OVA spores prevent OVA-induced food allergy in a mouse model and explored the potential underlying mechanisms. Method: Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot were used to confirm that CTB-OVA was expressed on B. subtilis spores. Female BALB/c mice were orally administered with B.s -CotC-CTB-OVA spores and B. subtilis spore control ( B.s -CotC and B.s -CotC-CTB) for 4 weeks. Then, sensitization and challenge with OVA were performed on mice. Fecal OVA-secretory IgA (sIgA) and serum OVA-IgE, IgG1, and IgG2a levels were measured by enzyme-linked immunosorbent assay (ELISA). The gut microbiome was analyzed by 16S rDNA sequencing. After challenge, diarrhea score, anaphylactic reactions score, splenocyte interleukin (IL)‐10, IL‐4, and interferon‐γ (IFN‐γ), and Treg levels were measured. mRNA of IL-10, IL-4, IFN‐γ, and Foxp3 were measured. Fecal microbiota transplant (FMT) was used to explore the mechanisms of microbiome in B. subtilis on food allergy. Results: Recombinant CTB-OVA was successfully expressed on the surface of B. subtilis . Oral administration of B.s -CotC-CTB-OVA can increase fecal OVA-sIgA, alleviate food allergy symptoms, and decrease serum OVA-IgE in mice with significance ( p < 0.05). Moreover, oral administration of B.s -CotC-CTB-OVA can significantly reduce serum OVA-IgG1, OVA-IgG2, IL-4, spleen mast cells, and eosinophil levels and significantly increase serum IL-10 and Treg levels ( p < 0.05). Additionally, microbiome analysis shows that oral administration of B.s -CotC-CTB-OVA can significantly increase the relative abundance of Muribaculaceae and significantly decrease the relative abundance of Alistipes. FMT partially reproduced the reduction in serum OVA-specific IgE, but did not significantly improve allergic symptom or diarrhea scores, suggesting that gut microbiota alterations may partially contribute to the immunological effects of B.s-CotC-CTB-OVA. Conclusion: These findings suggest that B.s -CotC-CTB-OVA spores may serve as a preventive oral antigen-delivery strategy to promote antigen-specific immune regulation and partially modulate microbiota-associated immune responses in OVA-induced food allergy.

  • Oral delivery of recombinant Bacillus subtilis expressing mSEB reduces intestinal Staphylococcus aureus colonization

    by Kaiyue Yang, Yunxing He, Xiaojie Zhou, Tongyan Ding, Shuyan Liu, Shaoxiang Lin, Xiaochun Liu, Zhenwen Zhou

  • Open Access

    Bacterial pathogen spectrum and antimicrobial resistance in positive pus cultures from hospitalized patients at a maternal and child healthcare specialty hospital in Shenzhen, China, 2021–2025

    by Tongyan Ding, Xiaochun Liu, Futing Liao, Shaoxiang Lin, Shuyan Liu, Shujuan Yang, Xiaojie Zhou, Qiaoxin Zhang, Zhenwen Zhou

    Objective: Pus culture and antimicrobial susceptibility testing play an important role in pathogen identification and the adjustment of empirical therapy for localized suppurative infections. This study aimed to investigate the distribution of major bacterial pathogens isolated from pus cultures and their susceptibility profiles to commonly used antimicrobial agents among hospitalized patients at Longgang District Maternity & Child Healthcare Hospital of Shenzhen City, in order to provide evidence for rational clinical antimicrobial use. Methods: We retrospectively collected pus culture records and aggregated antimicrobial susceptibility data from January 1, 2021 to December 31, 2025. Results: From 2021 to 2025, 586 non-duplicate bacterial isolates were recovered from positive pus cultures, of which 64.7% were Gram-negative and 35.3% were Gram-positive. The leading isolates were Escherichia coli (48.0%) and Staphylococcus aureus (22.5%), followed by Klebsiella pneumoniae subsp. pneumoniae (7.0%), Staphylococcus epidermidis (3.8%), Pseudomonas aeruginosa (2.4%), and Streptococcus agalactiae (1.4%). Positive cultures were mainly from the Departments of Pediatric Surgery, General Surgery, Gynecology, and Breast Surgery, with a bimodal age distribution peaking in young children and women of reproductive age; among Pediatric Surgery cases, males predominated, especially in the 0-3-year group. Extended-spectrum beta-lactamase production was detected in 28.1% of Escherichia coli and 20.0% of Klebsiella pneumoniae subsp. pneumoniae isolates. Escherichia coli showed high resistance to ampicillin, trimethoprim-sulfamethoxazole, and ciprofloxacin but remained highly susceptible to imipenem and amikacin. Klebsiella pneumoniae subsp. pneumoniae remained highly susceptible to amikacin, cefoxitin, and ertapenem despite resistance to several cephalosporins and ciprofloxacin. A subset of Staphylococcus aureus isolates was methicillin resistant, with frequent resistance to erythromycin and clindamycin, whereas vancomycin and linezolid retained good in vitro activity. Conclusions: Empirical antimicrobial therapy for localized suppurative infections in this maternal and child healthcare specialty hospital should be guided by local pathogen distribution and antimicrobial susceptibility surveillance, with coverage for both Enterobacterales and staphylococci.

  • Open Access

    Distribution and antimicrobial susceptibility profiles of bacterial isolates from vaginal discharge specimens among hospitalized patients in a tertiary maternal and child healthcare hospital in Shenzhen, China

    by Tongyan Ding, Xiaochun Liu, Shaoxiang Lin, Xiuju Liu, Xiaojie Zhou, Zhimin Zhao, Shujuan Yang, Futing Liao, Qiaoxin Zhang, Zhenwen Zhou

    Introduction: Abnormal vaginal discharge is a common and clinically important presenting complaint and reason for specimen submission, often suggesting lower genital tract disorders such as vaginal infections, and may adversely affect women’s reproductive health and pregnancy outcomes. This study aimed to investigate the distribution and antimicrobial susceptibility profiles of common bacteria isolated from vaginal discharge specimens submitted from hospitalized patients at Longgang District Maternity & Child Healthcare Hospital of Shenzhen City, in order to provide a reference for the interpretation of clinical specimen results and empirical antimicrobial therapy. Methods: Non-duplicate bacterial isolates recovered from vaginal discharge specimens collected from hospitalized patients between January 1, 2021 and December 31, 2025 were retrospectively analyzed, and the composition of common vaginal bacterial isolates, the age distribution of patients, and the antimicrobial susceptibility profiles of major isolates to commonly used antibiotics were assessed. Results: A total of 1,094 non-duplicate positive bacterial isolates were identified during 2021–2025, with Gram-positive bacteria predominating (65.2%). The major isolates were Streptococcus agalactiae , Escherichia coli , and Klebsiella pneumoniae subsp. pneumoniae . Most cases were from the obstetrics department, and the majority of patients were women aged 25–34 years. Antimicrobial susceptibility testing showed marked differences in antimicrobial susceptibility profiles among bacterial species: Streptococcus agalactiae remained highly susceptible to penicillins and vancomycin, but showed high resistance rates to clindamycin and tetracycline; Escherichia coli and Klebsiella pneumoniae subsp. pneumoniae had relatively high rates of extended-spectrum β-lactamase (ESBL) positivity, while remaining highly susceptible to amikacin, carbapenems, and tigecycline; some isolates also exhibited notable resistance to trimethoprim-sulfamethoxazole, fluoroquinolones, and certain β-lactam antibiotics. Discussion: Vaginal bacterial isolates from hospitalized patients were predominantly composed of Streptococcus agalactiae and members of the Enterobacteriaceae family, and were mainly derived from the obstetrics department and women of reproductive age. Marked differences in antimicrobial susceptibility profiles were observed among bacterial species, suggesting that maternal and child healthcare hospitals should strengthen local surveillance of isolate distribution and antimicrobial susceptibility in order to support more precise empirical therapy and antimicrobial stewardship.

  • Open Access

    Phenotypic and genomic characterization of NDM-producing Escherichia coli colonizing the pediatric gut in Shenzhen, China

    by Yunxing He, Hongmei Yang, Cuimei Liao, Xiaoying Ou, Kaiyue Yang, Tongyan Ding, Xiaojie Zhou, Xiuju Liu, Shuyan Liu, Zhenwen Zhou, et al.

    Carbapenem-resistant Enterobacterales, driven by New Delhi metallo-β-lactamases (NDMs), severely restrict treatment options and are increasingly detected outside hospitals. Yet, integrated genomic–phenotypic data on NDM-positive Escherichia coli colonizing the pediatric gut in China remain scarce. Antimicrobial susceptibility and bla NDM conjugation were tested. Whole-genome sequencing (WGS) profiled the resistome, virulome, and plasmid replicon types; multilocus sequence typing (MLST), core-gene MLST, and fimH alleles were analyzed. We assessed biofilm-forming capacity, screened gene–biofilm associations using Benjamini–Hochberg false discovery rate, and measured cytotoxicity and siderophore activity. Twenty-five NDM-positive E. coli were isolated from 1,189 children stool specimens. ST48 (ST10 complex) was the most frequent sequence type (6/25, 24%); fimH 41 was the most common fimH allele (4/25, 16%). All isolates were resistant to AMC, TZP, CXM, FOX, CAZ, CRO, CSL, ETP, and IMP, while none was resistant to tigecycline. All isolates transferred bla NDM by conjugation (frequency 1.0 × 10⁻⁴ to 9.0 × 10⁻⁴). WGS identified bla NDM-5 as predominant (24/25, 96%), with one bla NDM-1 (1/25, 4%); all isolates harbored multiple virulence and resistance genes. IncFIB (19/25, 76%) was the most common plasmid replicon. All isolates formed biofilms, including three strong producers; an exploratory screen suggested a positive association between espL4 carriage and biofilm formation ability. All isolates increased LDH release from NCM460 cells versus the ATCC 25922 control (low cytotoxicity), without significant differences among isolates; all isolates exhibited siderophore activity as determined by Chrome Azurol S assays. NDM-positive E. coli colonizing children in this study were dominated by bla NDM-5, frequently carried IncFIB plasmids, and readily transferred bla NDM. All isolates showed biofilm, siderophore activity, and epithelial cytotoxicity, with espL4 positively associated with biofilm. IMPORTANCE: This study provides an integrated genomic and phenotypic characterization of pediatric gut-derived New Delhi metallo-β-lactamase (NDM)-positive Escherichia coli isolates. These strains were dominated by bla NDM-5, carried extensive resistomes, and maintained a conserved set of virulence determinants that support colonization and persistence. The frequent presence of poly-replicon plasmids, particularly IncF-type backbones, underscores their high potential for resistance dissemination. Functionally, all isolates exhibited biofilm formation, siderophore activity, and epithelial cytotoxicity, with a hypothesis-generating signal linking espL4 to enhanced biofilm production. Together, these findings demonstrate that children can harbor high-risk, multidrug-resistant NDM-producing E. coli in their gut and emphasize the need for continued genomic surveillance and mechanistic studies to guide infection control and therapeutic strategies.


  • Open Access

    Distribution and antimicrobial resistance profiles of common blood culture isolates in a maternal and child health specialty hospital, Shenzhen (January 2021–October 2025), China

    by Tongyan Ding, Shaoxiang Lin, Kaiyue Yang, Xiaojie Zhou, Shuyan Liu, Xiaochun Liu, Qiaoxin Zhang, Zhenwen Zhou

    Objective: To investigate the distribution and antimicrobial resistance profiles of pathogens causing bloodstream infections (BSIs) in a maternal and child health hospital, providing evidence for rational clinical therapy. Methods: A retrospective analysis was conducted on 395 bacterial isolates recovered from positive blood cultures of inpatients at Longgang District Maternity & Child Healthcare Hospital of Shenzhen City between January 1, 2021 and October 31, 2025. Duplicate isolates from the same patient were excluded. Results: Among all isolates, Gram-positive bacteria accounted for 60.5% and Gram-negative bacteria for 39.5%. Coagulase-negative staphylococci (40.3%) were the most frequently detected, although many were likely contaminants. The major clinically relevant pathogens were Escherichia coli (28.6%), Streptococcus agalactiae (3.3%), Klebsiella pneumoniae subsp. pneumoniae (2.8%), and Staphylococcus aureus (2.3%). Escherichia coli showed a 44.3% Extended-Spectrum β -Lactamase (ESBL)-positive rate and elevated resistance to third-generation cephalosporins, with one carbapenem-resistant Enterobacteriaceae (CRE) isolate identified. Klebsiella pneumoniae exhibited overall low resistance levels. Among Staphylococcus aureus , methicillin-resistant Staphylococcus aureus (MRSA) accounted for 22.2%, all susceptible to vancomycin, linezolid, and tigecycline. Streptococcus agalactiae retained excellent β -lactam and glycopeptide susceptibility, whereas Streptococcus pneumoniae exhibited pronounced macrolide resistance. Conclusion: Escherichia coli and Staphylococcus aureus were the leading pathogens. The high ESBL rate in Escherichia coli and the detection of a CRE isolate indicate emerging β -lactam resistance risks. Although MRSA was detected, complete susceptibility to glycopeptides was preserved, highlighting the importance of ongoing monitoring.

  • Open Access

    Prevalence and characterization of Staphylococcus aureus isolated from patients with aerobic vaginitis in Shenzhen, Southern China

    by Yunxing He, Cuimei Liao, Xiuju Liu, Tongyan Ding, Kaiyue Yang, Xiaochun Liu, Shaoxiang Lin, Shuyan Liu, Zhimin Zhao, Yan Zhang, et al.

    Aerobic vaginitis (AV), characterized by vaginal inflammation and elevated pH, is associated with severe complications such as preterm delivery. Staphyloco